Clinical Trials on Multiple Endocrine Neoplasia Type 1 in Russian Federation
Total 1160 results
-
AstraZenecaRUSSCO (Russian Society of Clinical Oncology)CompletedOvarian, Peritoneal, Fallopian Tube Cancer, BRCAm+ in RussiaRussian Federation
-
University of JenaRecruitingChronic Myeloid Leukemia in Myeloid Blast CrisisGermany, Czechia, Russian Federation, Ukraine
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan, United States, Russian Federation, France, Mexico, Austria, Germany, Italy, Poland
-
NovartisCompletedType 2 Diabetes MellitusRussian Federation, Germany, United States
-
OMRIX BiopharmaceuticalsSuspendedOvarian Cysts | Endometriosis | AdhesionsSpain, United States, Mexico, Russian Federation, Germany
-
Karolinska InstitutetMedical University of Vienna; Oslo University Hospital; Sahlgrenska University... and other collaboratorsTerminatedAcute Myeloid LeukemiaCanada, Austria, Sweden, Russian Federation, Norway
-
Halozyme TherapeuticsCompletedStage IV Pancreatic CancerUnited States, Russian Federation
-
Mannkind CorporationCompletedType 1 Diabetes | Type 2 DiabetesUnited States, Brazil, Canada, Russian Federation
-
InSightecCompletedMultiple Myeloma | Bone MetastasesUnited States, Canada, Israel, Italy, Russian Federation
-
AstraZenecaBristol-Myers SquibbCompleted
-
Hoffmann-La RocheTerminatedLymphocytic Leukemia, ChronicRussian Federation
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Croatia, Italy, Slovakia, Denmark, Macedonia, The Former Yugoslav Republic of, Norway, Russian Federation, Finland, France, Poland, Greece, Romania, Sweden, Czech Republic, Argentina
-
Janssen Research & Development, LLCCompletedB-Cell Chronic Lymphocytic LeukemiaSpain, Russian Federation, Canada
-
Mannkind CorporationCompletedDiabetes, Type 2 | Diabetes, Type 1United States, Spain, Canada, Russian Federation, Czech Republic, Poland, Ukraine, United Kingdom
-
Benitec BioPharma LtdCompletedHead and Neck Squamous Cell CarcinomaAustralia, Russian Federation
-
SanofiCompletedType 2 Diabetes MellitusFrance, Russian Federation, United States, Argentina, Canada, Germany, South Africa, Italy, Netherlands, United Kingdom, Australia, Chile
-
Genentech, Inc.CompletedMetastatic Melanoma, BRAF V600 Mutation PositiveKorea, Republic of, Russian Federation, Israel, United States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United Kingdom, Denmark, Canada, France, Netherlands, Austria, Israel, Finland, Russian Federation, Croatia, Bulgaria, Poland, Ireland, Spain, Norway, Greece, Argentina, Germany
-
Sabine RhodeRuhr University of BochumUnknownGastric Cancer | Colorectal Cancer | Ovarian Cancer | Ascites | Pseudomyxoma Peritonei | Pancreas Cancer | Chemotherapeutic Toxicity | Pleural Effusion | Gallbladder Cancer | CUP | Appendix Cancer | Pleural Mesothelioma | Peritoneum Cancer | Peritoneum Neoplasm | Pleural CancerSingapore, France, Germany, Australia, Argentina, Austria, Belgium, Denmark, Italy, Poland, Russian Federation, Spain, Switzerland
-
AbbVieCompletedAcute Myeloid Leukemia (AML)Russian Federation
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Israel, Italy, Russian Federation, United Kingdom, Denmark, Austria, Serbia, Canada, Croatia, Australia, Greece, Ireland, Brazil, Spain, Argentina
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell CarcinomaChina, Argentina, Brazil, Russian Federation, Bulgaria, United States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusRussian Federation, Romania, United States, India, Puerto Rico
-
AbbVie (prior sponsor, Abbott)AlmedisCompletedSecondary HyperparathyroidismRussian Federation
-
TakedaCompletedDiabetes MellitusRussian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, China, India, Iran, Islamic Republic of, Korea, Republic of, Russian Federation, Poland, Japan, Italy, Canada, Greece
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, Puerto Rico, Russian Federation, United Kingdom, Denmark, France, Israel, Australia, Romania
-
AB ScienceRecruitingProgressive Multiple SclerosisSpain, Sweden, France, Greece, Italy, Poland, Russian Federation, Ukraine
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Poland, Romania, Russian Federation, Ukraine, India, Belgium, Mexico, Tunisia, Japan, Israel, Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, France, United States, Japan, Netherlands, Russian Federation, Bulgaria, United Kingdom, North Macedonia, South Africa, Italy, Finland
-
AstraZenecaCompletedType 2 DiabetesUnited States, Russian Federation, South Africa, Taiwan
-
Gilead SciencesTerminatedMultiple Myeloma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic LeukemiaUnited States, Czech Republic, Russian Federation
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, India, Russian Federation, Belgium, Spain, Israel, Croatia, Serbia, North Macedonia, South Africa, Slovenia, Brazil, Poland, Canada, Czechia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Russian Federation, United Kingdom, Canada, France, Netherlands, Belgium, Germany, Slovenia
-
CytokineticsCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States, Russian Federation
-
AB ScienceTerminatedMetastatic MelanomaFrance, Spain, Italy, United States, Czechia, Germany, Russian Federation
-
Affimed GmbHTerminatedLeukemia, B-CellAustria, Israel, Russian Federation, Poland, Czechia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, France, United Kingdom, Russian Federation, Germany, South Africa
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Israel, Poland, United Kingdom, Denmark, Spain, France, Austria, Norway, Russian Federation, Canada, Croatia, Argentina, South Africa, Australia, Ireland, Brazil, Finland
-
Hoffmann-La RocheCompletedOvarian CancerBelgium, Spain, Canada, Russian Federation, United Kingdom, Hungary, Italy, Poland, Netherlands
-
Kidney Cancer Research BureauCompletedCarcinoma, Renal Cell | Clear Cell Renal Cell CarcinomaRussian Federation
-
SanofiTerminatedDiabetes Mellitus, Type 2United States, Poland, Romania, Russian Federation, Ukraine, Malaysia, Philippines, Taiwan, Mexico, Lithuania, Slovakia, Indonesia, Thailand
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United States, India, Italy, Russian Federation, United Kingdom, Canada, Netherlands, Austria, Japan, Spain, Germany, Turkey
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Israel, Italy, Poland, Russian Federation, United Kingdom, Canada, Denmark, Sweden, Austria, Belgium, Spain, Ireland, Norway, Serbia, Finland, Portugal, Ukraine
-
Ionis Pharmaceuticals, Inc.CompletedType 2 Diabetes MellitusPoland, Romania, Russian Federation
-
SanofiRegeneron PharmaceuticalsTerminatedPancreatic NeoplasmUnited States, France, Canada, Poland, Romania, Russian Federation, Germany, Italy, Spain, Switzerland, Bulgaria, India, Belgium, Czech Republic, Mexico, Argentina, Hungary, Colombia, Slovakia, Chile, Austria, Greece, Puerto Rico, Cyprus
-
AstraZenecaCompletedType 2 Diabetes MellitusRussian Federation
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2Russian Federation, Spain, Germany, Australia, Austria, Israel, Czech Republic
-
Mologen AGCompletedAdvanced Colorectal CarcinomaUnited Kingdom, Germany, Austria, Czech Republic, France, Russian Federation
-
Hoffmann-La RocheCompletedRenal Cell Carcinoma | Chronic Myelogenous Leukemia | Malignant MelanomaCanada, India, Bulgaria, Russian Federation, Spain, South Africa, Slovakia